| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/08/2004 | WO2003056298A3 Sensitive coded detection systems |
| 01/08/2004 | WO2003054552A3 Automated system and method for processing specimens to extract samples for both liquid-based and slide-based testing |
| 01/08/2004 | WO2003050302A3 Tgnp activity or expression as marker for apoptosis |
| 01/08/2004 | WO2003050135A3 Use a parapox b2l protein to modify immune responses to administered antigens |
| 01/08/2004 | WO2003048760A3 Method and apparatus for detecting the presence of ammonium nitrate and a sugar or a hydrocarbon |
| 01/08/2004 | WO2003042233A3 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry |
| 01/08/2004 | WO2003035895A3 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample |
| 01/08/2004 | WO2003034024A3 Methods and apparatuses for analyzing biological samples by mass spectrometry |
| 01/08/2004 | WO2003027677A3 Method of attachment of a biomolecule to a solid surface |
| 01/08/2004 | WO2003018837A3 Method and diagnostic kit for the molecular diagnosis of pharmacologically relevant genes |
| 01/08/2004 | WO2003014138A3 Method for immobilizing compounds by means of nitron formation and arrangement for immobilizing compounds |
| 01/08/2004 | WO2003007800A3 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/08/2004 | WO2003003018A3 Method for identifying compounds for the therapy of aging of the cardiovascular system |
| 01/08/2004 | WO2003000859A3 G-protein coupled receptors |
| 01/08/2004 | WO2002099036A3 Inhibition of neurodegeneration |
| 01/08/2004 | WO2002098220A3 Pesticidal activity of functionalized alkenes |
| 01/08/2004 | WO2002095354A3 Methods and labeled molecules for determining ligand binding to steroid receptors |
| 01/08/2004 | WO2002095067A3 INTERFERON α-14 POLYMORPHISM |
| 01/08/2004 | WO2002095009A3 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer |
| 01/08/2004 | WO2002086497A3 Use of hypoxia inducible factor 2alpha for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertension |
| 01/08/2004 | WO2002080952A3 Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways |
| 01/08/2004 | WO2002079448A3 G-protein coupled receptors |
| 01/08/2004 | WO2002072780A3 Igf antagonist peptides |
| 01/08/2004 | WO2002066654A3 Drug metabolizing enzymes |
| 01/08/2004 | WO2002064797A3 Mitochondrial topoisomerase i |
| 01/08/2004 | WO2002059142A3 Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (mrp-1) and their use in diagnostic and therapeutic applications |
| 01/08/2004 | WO2002055697A3 Human rhinovirus assays, and compositions comprising anti-rhinoviral perturbagens |
| 01/08/2004 | WO2002053596A3 Antibodies to insulin-like growth factor i receptor |
| 01/08/2004 | WO2002053594A3 Inhibitors of memapsin 2 and use thereof |
| 01/08/2004 | WO2002048707A3 Electrochemical coagulation assay and device |
| 01/08/2004 | WO2002046751A3 Methods of predicting chemotherapy response |
| 01/08/2004 | WO2002046458A3 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 01/08/2004 | WO2002040702A3 Methods for the treatment of cancer and other diseases and methods of developing the same |
| 01/08/2004 | WO2002040634A3 Expression miniarrays and uses thereof |
| 01/08/2004 | WO2001055967A3 Image metrics in the statistical analysis of dna microarray data |
| 01/08/2004 | US20040006782 Non-human mammal mutant for expression of the alpha6 subunit of the nicotinic acetylcholine receptor, and use for screening substances that can interact with said receptor |
| 01/08/2004 | US20040006778 Comprises heat resistant polypeptide for preparing pharmaceuticals; drug biosynthesis; side effect reduction |
| 01/08/2004 | US20040006513 Anti-terrorism water quality monitoring system |
| 01/08/2004 | US20040006433 Genomic messaging system |
| 01/08/2004 | US20040006432 System and method for assisting diagnosis and treatment of temporomandibular joint conditions |
| 01/08/2004 | US20040006257 Detection, diagnosis, and monitoring of a medical condition or disease with artificial olfactometry |
| 01/08/2004 | US20040006219 Comprises membrane protein for diagnosis, prevention and treatment of cell proliferative and inflammatory disorders |
| 01/08/2004 | US20040006209 Comprises immunoglobulin which specifically binds staphylococcal g-protein and receptor sites for preventing and treating infections; gentic vaccines |
| 01/08/2004 | US20040006208 Comprises three-dimensional structure of bound immunoglobulin complex; antiinflammatory/anticarcinogenic; viricides |
| 01/08/2004 | US20040006207 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 01/08/2004 | US20040006205 Comprises g-protein coupled receptor polypeptides for diagnosis, prevention and treatment of cancers, infections and dyslipidemias |
| 01/08/2004 | US20040006113 Methods for nicotine replacement dosage determination |
| 01/08/2004 | US20040006016 Isolated nucleic acids molecules, designated 27875, 22025, 27420, 16319, 55092 and 10218 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors and fusion proteins |
| 01/08/2004 | US20040005997 Screening methods for identifying compounds that bind to or activate amylin receptors (AR) and regulate or potentially regulate skeletal muscle mass or function in vivo. Also disclosed are screening methods for identifying compounds that |
| 01/08/2004 | US20040005722 Reaction cell and operation method thereof |
| 01/08/2004 | US20040005718 Method of fixing biopolymers to a substrate using magnetic beads and biopolymer measuring equipment using the method |
| 01/08/2004 | US20040005716 Meter |
| 01/08/2004 | US20040005715 Portable apparatus for detection of chemical warfare agents; pollution control; chemical vapor sensor |
| 01/08/2004 | US20040005697 Apparatus comprised of hydrophilic surface and coupling matrix for detecting and analyzing nucleic acids, proteins, macromolecules and other haptens |
| 01/08/2004 | US20040005696 Substrate and method for measuring the electro-physiological properties of cell membranes |
| 01/08/2004 | US20040005688 Comprises dishevelled associated kinase (DAK) protein for diagnosis, prevention and treatment of cell proliferative diseases |
| 01/08/2004 | US20040005686 Crystalline structure of human MAPKAP kinase-2 |
| 01/08/2004 | US20040005683 Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 01/08/2004 | US20040005666 Methods and reagents for modulating cholesterol levels |
| 01/08/2004 | US20040005651 Method for metal analysis and speciation and biosensor for effecting the method |
| 01/08/2004 | US20040005649 Monoclonal antibody for monitoring and treating changes in tumor growth or metastasis |
| 01/08/2004 | US20040005647 Comprises monocolnal antibody for diagnosis and treatment of cancer; antitumor agents; tumor imaging |
| 01/08/2004 | US20040005646 Use of the S2-6 gene product as a diagnostic marker for cancer detection |
| 01/08/2004 | US20040005645 Human marker protein for diagnosing, prognosing and classifying esophageal tumors; immunoassay; tumor diagnosis |
| 01/08/2004 | US20040005644 Diagnosing, detecting, preventing and treating breast tumors; immunoassay |
| 01/08/2004 | US20040005643 Anti-human tenascin monoclonal antibody |
| 01/08/2004 | US20040005642 Comprises expression vectors coding antiproliferative agents; antisense agents; tumor diagnosis and treatment |
| 01/08/2004 | US20040005640 Screening blood and/or urine for presence of transformed alpha fetoprotein (TAFP); immunoassay; pregnancy test |
| 01/08/2004 | US20040005638 Determining concentration of target antibodies in mixtures; food analysis; disease diagnosis |
| 01/08/2004 | US20040005636 Method for obtaining the binding affinities of a peptide library to a protein |
| 01/08/2004 | US20040005635 Multicompartment particle and/or cell analyzing apparatus for measuring characteristics of particles/cells such as concentration, number, viability, classification and size |
| 01/08/2004 | US20040005634 System and method for determining differential protein expression, diagnostic biomarker discovery system and method of using the same, and protein biomarkers and therapeutic and diagnostic uses thereof |
| 01/08/2004 | US20040005633 Using chromatography to separate and sort subsets of peptides in protein mixtures |
| 01/08/2004 | US20040005632 Use of "tethering"; compounds can be in the form of an individual enantiomer, diasteromer, geometric isomer, or mixtures thereof; for drug discovery |
| 01/08/2004 | US20040005631 Diagnosing and treating autoimmune disease; drug screening; immunotherapy |
| 01/08/2004 | US20040005630 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 01/08/2004 | US20040005629 Natural ligand of orphan G protein coupled receptor GPR86 and methods of use |
| 01/08/2004 | US20040005627 Monitoring affinity reactions using membranes; microfluidics; colorimetric analysis |
| 01/08/2004 | US20040005626 Comprises nucleotide sequences coding membrane protein for diagnosing and treating inflammatory and tumor disorders |
| 01/08/2004 | US20040005622 Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers |
| 01/08/2004 | US20040005621 Method of determining a chemotherapeutic regimen based on ERCC1 expression |
| 01/08/2004 | US20040005619 Diagnosing osteoporosis and paget's diseases via identifying variable numbers of tandem repeats in allelic sequences coding parathyroid hormone related peptide (PTHrP) |
| 01/08/2004 | US20040005614 Labeling, fragmenting and immobilizing polynucleotides; genome analysis |
| 01/08/2004 | US20040005613 Detecting restriction fragment length polymorphisms associated with allelic mutation using peptide nucleic acids |
| 01/08/2004 | US20040005611 PNA probes, probe sets, methods and kits pertaining to the determination of Listeria |
| 01/08/2004 | US20040005610 Computational determination of alternative splicing |
| 01/08/2004 | US20040005607 Bis-diazo,triaryl and aryldiazo-N-arylphenazonium quencher moieties, substituted with electron withdrawing, electron donating substituents which induce polarity in delocalized aryl/diazo ring system; use as labels attached to biomolecules |
| 01/08/2004 | US20040005604 Comprises nucleotide sequences coding enzymatic polypeptide for degumming oil and food processing; antisense therapy |
| 01/08/2004 | US20040005598 Comprises nucleotide sequences coding protein upregulated in metastatic prostate cancer (PUMPCn) for diagnosis and treatment of tumors; antiproliferative agents; anticarcinogenic agents |
| 01/08/2004 | US20040005596 Gene amplification in cancer |
| 01/08/2004 | US20040005594 Identifying and characterizing modulators of nucleic acid processing enzymes; enzyme inhibitors |
| 01/08/2004 | US20040005592 Materials and methods relating to therapy and diagnosis using targeting of cells that express DCAL-Hy polypeptides |
| 01/08/2004 | US20040005589 Isomaltulose synthases, polynucleotides encoding them and uses therefor |
| 01/08/2004 | US20040005586 Exonuclease composition for prognosing and diagnosing cancer and infectious diseases |
| 01/08/2004 | US20040005585 Polynucleotide sequence assay |
| 01/08/2004 | US20040005582 Biospecific desorption microflow systems and methods for studying biospecific interactions and their modulators |
| 01/08/2004 | US20040005581 Comprises nucleotide sequences coding vanilloid receptor-like receptor (VR4) for diagnosing and treating pain, inflammation, neurodegeneration, cardiovascular, cancer and urogenital diseases; drug screening |
| 01/08/2004 | US20040005579 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005576 Comprises polypeptides for diagnosing, prognosing and preventing cancer, nervous system, developmental and metabolic disorders |
| 01/08/2004 | US20040005574 SIR2 activity |